Age-related Macular Degeneration Drugs Market to Hit USD 17.37 Billion by 2029 with 10.7% CAGR | MarketsandMarkets™ Delray Beach, FL, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The global AMD drugs market is set to grow from USD 10.46 billion in 2024 to USD 17.37 billion by 2029, reflecting a robust CAGR of 10.7%. This...

Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 7.4% by 2033: Visiongain Visiongain has published a new report: Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2023-2033: Forecasts by Disease Indication (AMD, Diabetic Macular Edema, Diabetic...

Global Macular Degeneration (AMD) and other retinal diseases drugs market is projected to reach at a market value of US$ 40.16 Billion by 2031: Visiongain Research Inc Visiongain has published a global macular degeneration (AMD) and other retinal diseases drugs market report 2021-2031.Forecasts By Indication (diabetic macular edema, diabetic retinopathy, retinal...